Saurabh Saha, Chief Executive Officer at Centessa Pharmaceuticals plc (CNTA), sold 63,693 shares at $16.89 ($1.1M) on 2024-11-20, disclosed to the SEC on 2024-11-22.
Open-market sale of $1.1M CNTA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.89 | 55,000 | $929K | 85.4% |
| 2 | $18.24 | 3,511 | $64K | 5.9% |
| 3 | $18.24 | 3,511 | $64K | 5.9% |
| 4 | $18.24 | 1,671 | $30K | 2.8% |
| Total | $17.07 avg | 63,693 | $1.1M | 100% |
| Filing → |
| CNTA | SELL | 2025-05-20 | $699K | — | Filing → |
| CNTA | SELL | 2025-04-22 | $1.4M | — | Filing → |
| CNTA | SELL | 2025-03-21 | $1.8M | — | Filing → |